Preventia Healthcare Inc., the exclusive distributor of nasal spray Covispray in the Philippines, warns the public on the counterfeit Covispray in the market. Currently, the company is working closely with the government to prevent further spread of the counterfeit products.
Counterfeit products are hazardous to consumers’ health. Covispray underwent intensive research and development, vigorous testing and clinical studies to ensure the effectivity of the product on minimizing and stopping the infection caused by the Covid-19 virus & Contaminants. The product’s technology is protected by 3 international patents.
To ensure that the authenticity of the product, purchase Covispray only on leading FDA-licensed drugstores & Retailers. Always check the irregularity of the price, packaging and bottle of Covispray. Preventia Healthcare Inc. also encourages the public to report sale and distribution of counterfeit Covispray.
For more details, please visit https://preventia.ph/covispray/